Ovulation induction medication only needs one injection
A new remedy to stimulate ovulation promises to innovate the processes of assisted reproduction. For all fertility treatments it is necessary to undergo ovulation induction, a process in which the follicles are stimulated to produce more than one ovule in this menstrual cycle. This can be done on a smaller scale in programmed intercourse and artificial insemination and with higher doses for in vitro fertilization.
For this, the remedies can be taken orally, but are most commonly applied by daily injections, which consists in one of the worst stages of treatment for women. But the recent drug called alfacorifolitropin is applied only once, which gives greater convenience to the fertilization process. In addition, it induces the ovary to produce more mature eggs per month, not just one or two as with traditional injections, consisting of a greater possibility of successful treatment.
Medication of alfacorifolitropina has action innovative and modern, one of its major advantages is that a single application of the substance equates to seven primary injections on the egg production resource, in addition to avoiding possible failures in the application of the medication for the introduction of the egg producing substance. > However, the substance is only given to patients with a low clinical risk of ovarian hyperstimulation syndrome. The main positive point is the practicality and efficiency of the medication, which operates for seven days and in the eighth day. The main positive point is the practicality and efficiency of the medication, which operates for seven days and in the eighth day a reassessment is performed to examine whether or not there is a need to integrate with other injections. However, contraindication is directed at women who have polycystic ovarian syndrome, who should not take the drug.
Available in Brazil, the recent drug has proven stability and efficiency in clinical studies presented internationally. Treatment with alfacorifolitropine was demonstrated with 38.9% efficacy in pregnancy, approaching the results of patients who received the seven dosages of traditional treatment that reached 38.1%.
But the disadvantage is that with only one administration can the ovaries are less stimulated and thus fewer eggs are obtained. However, this is the current trend, improving the results of in vitro fertilization makes it possible to achieve pregnancy with fewer embryos transferred. Another disadvantage of this new drug would be that even with one dose, there is still the risk of having excessive stimulation of the ovaries in patients sensitive to the drug.
After being diagnosed with plagiocephaly, a bad skull formation, the four-month-old baby Jonas Gutierrez was forced to wear a special helmet to correct the problem. As a form of solidarity, the whole family began using the attachment to support the boy. Positional plagiocephalism develops by a vicious positioning of the head, for example when babies are sleeping or sitting in the same position.
Puberty is already a difficult phase when it happens within the time expected, which will tell you when it occurs ahead of schedule! The so-called early puberty is characterized when the body starts to exhibit adult characteristics earlier than expected: before eight years for girls and before nine for boys.